Home The Word Brain	My Amedeo FAQ Privacy About
	Chinese Coaching Already know some Chinese? Stay on track with structured, one-on-one coaching to make steady, long-term progress. By Meng Wu and BSK.

Parkinson's Disease

Free Subscription Articles published in J Neurochem Retrieve available abstracts of 35 articles: HTML format

Single Articles

December 2025
1. D'ANGLEMONT DE TASSIGNY X, Jimenez-Medina A, Lopez-Lopez I, Lopez-Barneo J, et al
   Phosphodiesterase Inhibition Increases Striatal GDNF and Protects Against Preclinical Parkinsonism.
   J Neurochem. 2025;169:e70321.
   PubMed     Abstract available
   
   
   September 2025
2. USENKO TS, Basharova KS, Bezrukova AI, Grigor'eva EV, et al
   Restoration of Lysosomal Hydrolase Activities by LRRK2 Inhibition in GBA1- and LRRK2-Associated Parkinson's Disease Patient-Derived Cells.
   J Neurochem. 2025;169:e70214.
   PubMed     Abstract available
   
   
   July 2025
3. TNG TJW, Leow DMK, Goh G, Wang Z, et al
   Ergothioneine Treatment Ameliorates the Pathological Phenotypes of Parkinson's Disease Models.
   J Neurochem. 2025;169:e70168.
   PubMed     Abstract available
   
   
   June 2025
4. HO MS
   Clearance Pathways for alpha-Synuclein in Parkinson's Disease.
   J Neurochem. 2025;169:e70124.
   PubMed     Abstract available
   
   
   
5. HUANG A, Foti RS, Gunawardana CG, Shen H, et al
   Bioanalytical Considerations for Biomarkers of Parkinson's Disease.
   J Neurochem. 2025;169:e70131.
   PubMed     Abstract available
   
   
   May 2025
6. JING Y, Zhu H, Yao P, Chen Y, et al
   IgD-CD38-B Cell Partially Mediates the Protective Effect of Higher Serum Triacylglycerol (53:4) Levels Against Parkinson's Disease.
   J Neurochem. 2025;169:e70067.
   PubMed     Abstract available
   
   
   April 2025
7. MUSTHAFA T, Nizami SK, Mishra A, Hasan G, et al
   Altered Mitochondrial Bioenergetics and Calcium Kinetics in Young-Onset PLA2G6 Parkinson's Disease iPSCs.
   J Neurochem. 2025;169:e70059.
   PubMed     Abstract available
   
   
   March 2025
8. LI Y, Jiang J, Li J, Liu S, et al
   Exosome-Derived CDC42 From Hypoxia-Pretreated Neural Stem Cells Inhibits ACSL4-Related Ferroptosis to Alleviate Vascular Injury in Parkinson's Disease Mice Models.
   J Neurochem. 2025;169:e70027.
   PubMed     Abstract available
   
   
   February 2025
9. PRATES-RODRIGUES M, Schweizer BLA, de Paula Gomes C, Ribeiro AM, et al
   Challenges and Opportunities in Exploring Non-Motor Symptoms in 6-Hydroxydopamine Models of Parkinson's Disease: A Systematic Review.
   J Neurochem. 2025;169:e70008.
   PubMed     Abstract available
   
   
   
10. POKHAREL PV, Newchurch AM, Overby SC, Spease CA, et al
    Oxidative Stress Suppresses Trk Signaling While Stimulating JNK-Mediated Endocytosis and Cleavage of p75(NTR): A Targetable Pathway for Neuroprotection in a Parkinson's Disease Model.
    J Neurochem. 2025;169:e70010.
    PubMed     Abstract available
    
    
    
11. PICCOLI M, Barbato L, Maiorana NV, Mingione A, et al
    Direct Current Stimulation (DCS) Modulates Lipid Metabolism and Intercellular Vesicular Trafficking in SHSY-5Y Cell Line: Implications for Parkinson's Disease.
    J Neurochem. 2025;169:e70014.
    PubMed     Abstract available
    
    
    November 2024
12. WITZIG V, Pjontek R, Tan SKH, Schulz JB, et al
    Modulating the cholinergic system-Novel targets for deep brain stimulation in Parkinson's disease.
    J Neurochem. 2024 Nov 18. doi: 10.1111/jnc.16264.
    PubMed     Abstract available
    
    
    October 2024
13. 
    RETRACTION: The oxysterol 27-hydroxycholesterol regulates alpha-synuclein and tyrosine hydroxylase expression levels in human neuroblastoma cells through modulation of liver X receptors and estrogen receptors-relevance to Parkinson's disease.
    J Neurochem. 2024 Oct 15. doi: 10.1111/jnc.16240.
    PubMed     Abstract available
    
    
    September 2024
14. GOLDSTEIN DS, Sullivan P, Holmes C
    Cerebrospinal fluid concentration gradients of catechols in synucleinopathies.
    J Neurochem. 2024;168:2926-2934.
    PubMed     Abstract available
    
    
    
15. ONAL G, Yalcin-Cakmakli G, Ozcelik CE, Boussaad I, et al
    Variant-specific effects of GBA1 mutations on dopaminergic neuron proteostasis.
    J Neurochem. 2024;168:2543-2560.
    PubMed     Abstract available
    
    
    June 2024
16. ALVES BDS, Schimith LE, da Cunha AB, Dora CL, et al
    Omega-3 polyunsaturated fatty acids and Parkinson's disease: A systematic review of animal studies.
    J Neurochem. 2024 Jun 24. doi: 10.1111/jnc.16154.
    PubMed     Abstract available
    
    
    May 2024
17. LI J, Ng KW, Sung CC, Chung KKK, et al
    The role of age-associated alpha-synuclein aggregation in a conditional transgenic mouse model of Parkinson's disease: Implications for Lewy body formation.
    J Neurochem. 2024 May 1. doi: 10.1111/jnc.16122.
    PubMed     Abstract available
    
    
    March 2024
18. NETZAHUALCOYOTZI C, Santillan-Cigales JJ, Adalid-Peralta LV, Velasco I, et al
    Infiltration of immune cells to the brain and its relation to the pathogenesis of Alzheimer's and Parkinson's diseases.
    J Neurochem. 2024 Mar 29. doi: 10.1111/jnc.16106.
    PubMed     Abstract available
    
    
    
19. PLACIDO E, Koss DJ, Outeiro TF, Brocardo PS, et al
    Altered hippocampal doublecortin expression in Parkinson's disease.
    J Neurochem. 2024 Mar 14. doi: 10.1111/jnc.16101.
    PubMed     Abstract available
    
    
    
20. KALINICHENKO LS, Kohl Z, Muhle C, Hassan Z, et al
    Sex-specific pleiotropic changes in emotional behavior and alcohol consumption in human alpha-synuclein A53T transgenic mice during early adulthood.
    J Neurochem. 2024;168:269-287.
    PubMed     Abstract available
    
    
    January 2024
21. CARMONA A, Carboni E, Gomes LC, Roudeau S, et al
    Metal dyshomeostasis in the substantia nigra of patients with Parkinson's disease or multiple sclerosis.
    J Neurochem. 2024 Jan 5. doi: 10.1111/jnc.16040.
    PubMed     Abstract available
    
    
    December 2023
22. ZHANG F, Yang D, Li J, Du C, et al
    Synaptotagmin-11 regulates immune functions of microglia in vivo.
    J Neurochem. 2023;167:680-695.
    PubMed     Abstract available
    
    
    
23. RENTSCH P, Egan T, Kuriakose A, Stayte S, et al
    The ratio of M1 to M2 microglia in the striatum determines the severity of L-Dopa-induced dyskinesias.
    J Neurochem. 2023;167:633-647.
    PubMed     Abstract available
    
    
    November 2023
24. BILLINGS JL, Hilton JBW, Liddell JR, Hare DJ, et al
    Fundamental Neurochemistry Review: Copper availability as a potential therapeutic target in progressive supranuclear palsy: Insight from other neurodegenerative diseases.
    J Neurochem. 2023;167:337-346.
    PubMed     Abstract available
    
    
    
25. SONG DY, Yuan L, Cui N, Feng C, et al
    alpha-Synuclein induces deficiency in clathrin-mediated endocytosis through inhibiting synaptojanin1 expression.
    J Neurochem. 2023;167:461-484.
    PubMed     Abstract available
    
    
    September 2023
26. WANG J, Joseph S, Vingill S, Dere E, et al
    Loss of the parkinsonism-associated protein FBXO7 in glutamatergic forebrain neurons in mice leads to abnormal motor behavior and synaptic defects.
    J Neurochem. 2023 Sep 27. doi: 10.1111/jnc.15962.
    PubMed     Abstract available
    
    
    
27. MUHAMMAD B, Li H, Gu Y, Xue S, et al
    IL-1beta/IL-1R1 signaling is involved in the propagation of alpha-synuclein pathology of the gastrointestinal tract to the brain.
    J Neurochem. 2023;166:830-846.
    PubMed     Abstract available
    
    
    
28. CHENG JY, Deng YT, Yu JT
    The causal role of circulating amino acids on neurodegenerative disorders: A two-sample Mendelian randomization study.
    J Neurochem. 2023;166:972-981.
    PubMed     Abstract available
    
    
    July 2023
29. WARTH PEREZ ARIAS CC, Silbern I, Caldi Gomes L, Wartmann H, et al
    Proteomic analysis of the human hippocampus identifies neuronal pentraxin 1 (NPTX1) as synapto-axonal target in late-stage Parkinson's disease.
    J Neurochem. 2023 Jul 28. doi: 10.1111/jnc.15924.
    PubMed     Abstract available
    
    
    June 2023
30. GASPAROTTO J, Somensi N, Girardi CS, Bittencourt RR, et al
    Is it all the RAGE? Defining the role of the receptor for advanced glycation end products in Parkinson's disease.
    J Neurochem. 2023 Jun 28. doi: 10.1111/jnc.15890.
    PubMed     Abstract available
    
    
    
31. HE H, Zhang Q, Liao J, Lei J, et al
    METTL14 is decreased and regulates m(6) A modification of alpha-synuclein in Parkinson's disease.
    J Neurochem. 2023 Jun 13. doi: 10.1111/jnc.15882.
    PubMed     Abstract available
    
    
    
32. BARINGER SL, Simpson IA, Connor JR
    Brain iron acquisition: An overview of homeostatic regulation and disease dysregulation.
    J Neurochem. 2023;165:625-642.
    PubMed     Abstract available
    
    
    April 2023
33. MASUKAWA D, Kitamura S, Tajika R, Uchimura H, et al
    Coupling between GPR143 and dopamine D2 receptor is required for selective potentiation of dopamine D2 receptor function by L-3,4-dihydroxyphenylalanine in the dorsal striatum.
    J Neurochem. 2023;165:177-195.
    PubMed     Abstract available
    
    
    
34. BRONTESI L, Imberdis T, Ramalingam N, Dettmer U, et al
    The effects of KTKEGV repeat motif and intervening ATVA sequence on alpha-synuclein solubility and assembly.
    J Neurochem. 2023;165:246-258.
    PubMed     Abstract available
    
    
    February 2023
35. CHEN YH, Kuo YY, You YQ, Lin YT, et al
    Endonuclease VIII-like 1 deficiency potentiates nigrostriatal dopaminergic neuron degeneration in a male mouse model of Parkinson's disease.
    J Neurochem. 2023 Feb 24. doi: 10.1111/jnc.15794.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Parkinson's Disease is free of charge.